FINCK BARBARA K — SEC insider filings
SEC reporting owner CIK 1242116. 10 insider filings on record with FilingPulse; latest filed 2026-08-27.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2022-03-18 to 2026-08-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 6,756 shares, $8,310 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: purchase of 6,756 shares @ $1.23 ($8,310) in Comera Life Sciences Holdings, Inc., filed 2023-02-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Comera Life Sciences Holdings, Inc. (CMRA) | Director | 2 | 1 leg · 6,756 sh · $8,310 | — | 3 |
| Forte Biosciences, Inc. (FBRX) | Director | 8 | — | — | 14 |
Insider filings — FINCK BARBARA K
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-27 | 4 | Forte Biosciences, Inc. (FBRX) | Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 166 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 7,000 (derivative) · Disposition to issuer (D): 31,000 (derivative) · +1 more | EDGAR |
| 2025-03-21 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-03-25 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2023-09-20 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-02-14 | 4/A | Comera Life Sciences Holdings, Inc. (CMRA) | Purchase (P): 6,756 @ $1.23 · Purchase (P): 6,756 (derivative) @ $0.25 | EDGAR |
| 2023-01-06 | 4 | Comera Life Sciences Holdings, Inc. (CMRA) | Grant/award (A): 6,756 @ $1.23 · Grant/award (A): 6,756 (derivative) @ $0.25 | EDGAR |
| 2022-06-02 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-05-16 | 4/A | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 4,166 (derivative) @ $0 | EDGAR |
| 2022-03-18 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-03-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1242116 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs